NationalStockNumber.INFO
Worldwide distributor of NSN parts and consumables located in the USA.
Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
043940 - Chemicals noi
635 - Chemicals, other than drugs or sundries
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
C - Chemical corps items and all other chemicals not covered in other classificatons. note: when an item has a chemical proper shipp
W - Rating variable
Z - No special type of cargo code applicable
Questions & Answers: |
|
| What are the historical prices recorded for this stock number? | |
| Historical data shows pricing from $4,865.18 to $8,108.64.. | |
| Does NSN 6810-00-797-8619 have a shelf life? | |
| No. There is no shelf life applicable for this NSN. | |
| What NATO entities are users of this NSN? | |
| Department Of The Navy | |
| What is the NIIN of NSN 6810-00-797-8619? | |
| 007978619 or 00-797-8619 | |
| Does NSN 6810-00-797-8619 require demilitarization? | |
| Yes - ITAR Controlled | |
| What is the most recent solicitation for NSN 6810-00-797-8619? | |
| No solicitations for this NSN. | |
| When was this national stock number assigned to the federal catalog? | |
| Jan 01, 1962 | |
Ld50 lc50 mixture: ld50 mouse =1680mg/kg
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: acute: at higher level concentration
may cause tremor,diarrhea,vomiting or effect cns cause drowsiness
or hypertension. Chronic: not known.
effects of overexposure: skin or lung irritation are the first symptoms
of overexposure.At higher concentration may cause tremor,diarrhea,
vomiting or effect the cns causing drowsiness or hypertension.
medical cond aggravated by exposure: not known
First aid: skin: wash with soap and water. Eyes: flush eyes thoroughly
with potable water for 15 minutes. Inhalation: remove to fresh
air,seek medical attention.
Hcc: n1
melt/freeze pt: m.P/f.P text: 1020f,549c
spec gravity: 3.464
appearance and odor: white crystals, colorless
Stability indicator/materials to avoid: yes
none noted
stability condition to avoid: extreme heat
hazardous decomposition products: none noted
Waste disposal methods: dispose of collected material in accordance with
local,state and federal regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: lithium bromide
cas: 7550-35-8
rtecs #: oj5755000
fraction by wt: >99%
other rec limits: 5mg/cum as n dust
Health hazards acute and chronic: acute: irritation of skin and eyes. In
event of over-exposures, burns may occur to tissues. Chronic:
dermatitis (cracking and reddening of skin) may develop after
prolonged or repeated skin contact w ith product. Long-term
over-exposure via inhalation or ingestion can produce symptoms
similar to those described for other lithium compounds (i. E. Rash,
ringing in ears, nausea, vomiting, diarrhea, d ifficulty speaking,
drowsiness, twitching, visual disturbances and coma). Inorganic
bromides (such as lithium bromide) can also cause rashes, which
resemble acne, after prolonged ingestion or inhalati on
overexposures.
effects of overexposure: eyes: irritation, pain, reddening of eye
tissue, damage to eye tissues. Skin: dehydrating action,
irritation, burns, itching, pain, reddening, dermatitis. Skin
absorption: not significant route of ex posure. Inhalation: dust
may irritate eyes, nose, respiratory system, ringing in ears,
nausea, vomiting, diarrhea, drowsiness, twitching, blurred vision,
rashes (which resemble acne). Ingestion: not a nticipated during
normal circumstances. Large doses can impact cns, drowsiness,
stumbling, dizziness, rash, ringing in ears, nausea, vomiting,
diahrrea, difficulty speaking, drowsiness, twitching, vis ual
disturbances, coma.
medical cond aggravated by exposure: pre-existing respiratory, skin,
central nervous system, and kidney conditions, significant
cardiovascular or renal disease, sodium and water imbalance,
hypothyroidism. Alertness may be impaired.,
First aid: skin exposure: immediately begin decontamination with running
water. Remove contaminated clothing,taking care not to contaminate
eyes. Get medical attention. Eyes: open victim's eyes while under
gentl e running water. Have victim roll eyes. Minimum flushing is
for 15 minutes. Get medical attention. Inhalation: if dusts of this
product are inhaled, move victim to fresh air. If necessary, use
artific ial respiration to support vital functions. Ingestion:
call physician or poison control center for most current
information. Induce vomiting. Victim should drink milk, egg whites,
or large quantities of water.
Hcc: n1
melt/freeze pt: =549.C, ######f
spec gravity: 3.464
evaporation rate & reference: n/a(buac=1)
solubility in water: soluble
appearance and odor: white, crystalline solid; no odor.
Stability indicator/materials to avoid: yes
this product is not compatible with strong acids and strong bases.
stability condition to avoid: avoid mixing this product with
incompatible chemicals.
hazardous decomposition products: thermal decomposition of the
components of this product include hydrogen bromide and lithium
compounds.
conditions to avoid polymerization: will no occur.
Waste disposal methods: dispose of in accordance with federal, state and
local solid waste disposal regulations. This chemical, if unaltered
by use, may be disposed of by treatment at a permitted facility or
as advised by yo ur local solid waste regulatory authority. Epa
waste number: not applicable to this product.
Ingred name: lithium bromide
cas: 7550-35-8
rtecs #: oj5755000
> wt: 99.
osha pel: 5mg/m3 resp
acgih tlv: 3mg/m3 resp
Ld50 lc50 mixture: ld50 (oral, rat) 1800 mg/kg
routes of entry: inhalation: yes skin: yes ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: acute: in an occupational setting, the
chief health effect anticipated after overexposure would be
irritation of contaminated skin and eyes. Prolonged overexposures
mayburn contaminted tissues. Chroni c: prolonged or repeated skin
exposures can cause dermatitis (dry, red skin). Long-term
inhalation or ingestion overexposure may produce symptoms similar
to those described for other lithium compounds (e.G., rash,
ringing in the ears, nausea, vomiting, diarrhea, difficulty
speaking, drowsiness, twitching, visual disturbances, and coma.)
prolonged/repeated inhalation/ingestion of inorganic bromides can
cause rashes which resemble acne.
explanation of carcinogenicity: lithium bromide is not found on the
following lists: ntp, iarc, federal osha. Lithium bromide is
neither considered to be nor suspected to be a cancer-causing agent
by these agencies.
effects of overexposure: prolonged overexposures mayburn contaminted
tissues. inhalation of dust may irritate mouth, nose and other
tissues of respiratory system. Prolonged overexposures may burn
contaminted tissues. inhala tion of dust may irritate mouth, nose
and other tissues of respiratory system. Skin contact can cause
itching, dermatitis (dry, red skin). Ingestion can cause rashes,
ringing in the ears, nausea, vom iting, diarrhea, difficulty
speaking, drowsiness, twitching, blurred vision, coma.
medical cond aggravated by exposure: pre-existing respiratory, skin,
central nervous system, and kidney conditions, significant
cardiovascular or renal disease, sodium and water imbalance,
hypothyroidism. Alertness may be impaired.
First aid: skin exposure: immediately begin decontamination with running
water. Remove contaminated clothing,taking care not to contaminate
eyes. Get medical attention. Eyes: open victim's eyes while under
gentl e running water. Have victim roll eyes. Minimum flushing is
for 15 minutes. Get medical attention. Inhalation: if dusts of this
product are inhaled, move victim to fresh air. If necessary, use
artific ial respiration to support vital functions. Ingestion: call
physician or poison control center for most current information. Do
not induce vomiting. If conscious have victim rinse mouth with
water.
Hcc: n1
nrc/state lic num: not relevant
boiling pt: =1265.C, 2309.F
melt/freeze pt: =549.C, ######f
decomp temp: decomp text: not provided
spec gravity: 3.464
solubility in water: 61 g/100 ml @ 28c
appearance and odor: white, crystalline solid; no odor.
corrosion rate: not provided
Stability indicator/materials to avoid: yes
this product is not compatible with strong acids and strong oxidizers.
stability condition to avoid: avoid mixing this product with
incompatible chemicals.
hazardous decomposition products: thermal decomposition of this product
include hydrogen bromide and lithium compounds.
Waste disposal methods: dispose of in accordance with federal, state and
local solid waste disposal regulations. This chemical, if unaltered
by use, may be disposed of by treatment at a permitted facility or
as advised by yo ur local solid waste regulatory authority. Epa
waste number: not applicable to this product.
Ingred name: lithium bromide
cas: 7550-35-8
rtecs #: oj5755000
> wt: 99.
other rec limits: 4 mg/m3 (mfr)
osha pel: 15 mg/m3 (tdust)
osha stel: 5 mg/m3 (rdust)
acgih tlv: 10 mg/m3 (tdust)
acgih stel: 3 mg/m3 (rdust)